Using VSV for Protease Evolution
Author Information
Author(s): Francesco Costacurta, Stefanie Rauch, Dorothee von Laer, Emmanuel Heilmann
Primary Institution: Medical University of Innsbruck
Hypothesis
Can vesicular stomatitis virus (VSV) be used as a safe platform for studying antiviral resistance mutations?
Conclusion
The protocol allows for the safe selection of antiviral resistance mutations using VSV without the need for actual pandemic viruses.
Supporting Evidence
- VSV is a harmless virus that can be used to study resistance without the risk of using dangerous pathogens.
- The protocol allows for high-throughput sequencing of resistance mutations.
- Using VSV helps avoid gain-of-function research concerns associated with pandemic viruses.
Takeaway
This study shows how scientists can use a harmless virus to learn about how other viruses might resist medicines, helping to keep people safe.
Methodology
The study presents a protocol for using VSV to select for antiviral resistance mutations by replacing parts of its genome with transgenes from other viruses.
Limitations
The study does not address the potential for unintended consequences of using a surrogate virus.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website